
Indoco Remedies Ltd
NSE:INDOCO

Operating Margin
Indoco Remedies Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | Company | Market Cap |
Operating Margin |
||
---|---|---|---|---|---|
IN |
![]() |
Indoco Remedies Ltd
NSE:INDOCO
|
24B INR |
2%
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
708B USD |
40%
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
3%
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
369.6B USD |
26%
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2T DKK |
48%
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
208.2B CHF |
33%
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
182.1B CHF |
33%
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
162.8B GBP |
24%
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
196.2B USD |
34%
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD |
11%
|
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
133.7B USD |
27%
|
Indoco Remedies Ltd
Glance View
Indoco Remedies Ltd. engages in manufacturing and marketing of Formulations (Finished Dosage Forms) and active pharmaceutical ingredients. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2005-01-07. The firm is an integrated, research-oriented pharma company engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The firm's geographical segments include India and Outside India. The firm has nine domestic marketing divisions with a brand portfolio in various therapeutic segments, including Gastrointestinal, Respiratory, Anti-Infective, Stomatologicals, Ophthalmic, Nutritionals, Cardiovascular, Anti-Diabetics, Pain Management and Gyneacology. The Company’s brands include Cyclopam, Febrex Plus, Sensodent-K, Karvol Plus, ATM, Oxipod, Cital, Sensoform, Sensodent-KF, Cal-Aid, Cloben-G, Glychek, Kidodent, Carmicide, Rexidin, MCBM and Methycal.

See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Indoco Remedies Ltd's most recent financial statements, the company has Operating Margin of 2.2%.